
    
      This is a prospective, multi-center, non-randomized, post-market study conducted within the
      United States. There will be two independent components (Phases) to this study. Phase 1 will
      involve data collection to describe the home infusion pump programming workflow and the
      process that was used to introduce the new CADD®-Solis VIP System to each home healthcare
      organization. This phase is further broken down into data collection consisting of four
      parts: drug protocol library creation and development within the CADD™ Solis Medication
      Safety Software Administrator, pump programming, home care implementation, and overall
      workflow and new smart pump implementation. Phase 2 will involve data collection from
      patients that receive a prescription requiring use of the CADD®-Solis VIP pump.
    
  